CHIRP brings scientists and clinicians from various disciplines throughout Washington University together to conduct clinical research using psychedelics as medical treatment. Through collaboration across disciplines, our research team investigates the how, why and for whom psychedelic treatments may be effective, and how those treatments may work in real-world settings.
The CHIRP team supports researchers interested in leading clinical trials with psychedelics. If you have a research idea, schedule a consultation with the team to get started!
News
Advancing Psychedelic-Assisted Therapy in Missouri (MO-PAT): Innovation at the Speed of Safety
Drs. Adams, Gettinger, Dell, Cabassa and Nicol discuss the infrastructure necessary to safely and equitably utilize PAT as a treatment for mental disorders.
Your brain on shrooms- how psilocybin resets neural networks
Dr. Nicol and her team use neuroimaging to investigate changes in communication pathways connecting brain regions after taking psilocybin. Read the article here:
Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science
Check out this journal article that explores the use of psychedelic-assisted psychotherapy (PAT) to treat different mental health conditions such as post-traumatic stress disorder (PTSD), depression, and substance abuse.
Helpful information
Join us at an upcoming CHIRP Event
Funding for CHIRP and our research initiatives provided by:
- This work was made possible by the Center for Holistic Interdisciplinary Research in Psychedelics (CHIRP) at Washington University in St. Louis, a Transcend Research Initiative funded by the WashU Here & Next Strategic Plan.
